| Also known as |
Levitra |
| Blood pressure |
Can cause a transient decrease in blood pressure |
| Chemical name |
Vardenafil hydrochloride |
| Dosage (medical) |
10 mg taken orally approximately 60 minutes before sexual activity, adjustable based on efficacy and tolerability |
| Dosage (sports) |
Not applicable |
| Effects |
Improved erectile function and response to sexual stimulation |
| Formula |
C23H32N6O4SВ·HCl |
| Half-life |
4-5 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specific, general health checks may monitor effects |
| Main action |
Enhances erectile function by increasing blood flow to the penis |
| Side effects |
Headache, flushing, nasal congestion, dyspepsia, dizziness |
| Storage conditions |
Store at room temperature between 15В°C and 30В°C (59В°F and 86В°F) |
| Strength |
60 mg |
| Substance class |
Phosphodiesterase type 5 inhibitor |
| Trade name |
Levitra, Staxyn |
| Use in sports |
None, not applicable |
| Water Retention |
No significant effect |
| Manufacturer |
Pharmaceutical |
